News & Articles
ABLATOM launches the first biomedical LIBS microscope in a hospital setting
ABLATOM deploys its LIBS microscope at the Grenoble Alpes University Hospital (CHUGA) to revolutionize patient diagnostics
Roche presents new data highlighting advances in Alzheimer’s diagnostics
Roche’s Elecsys Amyloid Plasma Panel shows high accuracy in ruling out Alzheimer's, offering new hope for early and less invasive diagnostics
Introducing iQue's 2nd edition high-throughput cytometry handbook
Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve outpatient respiratory treatment
QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions
Cervical cancer treatment breakthrough cuts risk of death by 40%
Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs
New drug combination targets treatment-resistant ovarian cancer
With fewer side effects than traditional therapies, this innovative treatment could redefine care for patients facing limited options
Oxford researchers secure funding for world's first ovarian cancer prevention vaccine
Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer
Key partnership to accelerate adoption of image management and AI digital pathology workflows
Learn more about the PathPresenter and Paige collaboration at an exclusive preconference workshop on November 3 at Pathology Visions 2024 conference
Pipettes take small molecule inhibitors from discovery to clinical trials
INTEGRA Biosciences supplies RAPT Therapeutics in San Francisco, USA, with pipettes to accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory diseases and cancers
Clario and PathAI collaborate to deliver integrated solution for GI clinical trials
Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders
METTLER TOLEDO and MACHEREY-NAGEL take water testing to a new level
Collaboration offers users compact and powerful analysis tools for water testing
Fujifilm Wako Europe – Your partner in chemical analysis
Fujifilm presents a portfolio of comprehensive brochures discussing pharmaceutical analysis of pesticide residual analysis and analyzing nitrosamine contaminants, combined with environmental topics such as substance limits in water and food
Yourgene Health Cystic Fibrosis assay receives IVDR accreditation
The Yourgene Cystic Fibrosis Base assay is a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment
Colossal achieves multiple scientific firsts in progress towards thylacine de-extinction
Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extinction crisis
Fujifilm Wako expands drug discovery capabilities with advanced CRO services
Fujifilm Wako Chemicals Europe is accelerating drug discovery and development by providing a range of services encompassing rabbit monoclonal antibody discovery, AI-driven drug discovery, neural cell assay services, cyclic peptide discovery, and more
bioMérieux receives CE marking for VIDAS VITAMIN B12 TOTAL
For use on all VIDAS immunoanalyzers, VIDAS VITAMIN B12 TOTAL is an automated quantitative blood test that measures total vitamin B12 concentration
Novel diagnostic assay for gastric and gastroesophageal junction cancer receives CE Mark approval
Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Metabolomics masterclass webinar series
Register now to join our 3-part webinar series from October
QIAGEN Digital Insights expands collaboration with Neo4j to advance biomedical data analysis
New agreement brings leaders in biomedical knowledge solutions and knowledge graph technologies together to aid the biopharmaceutical industry in analytics-driven drug discovery
QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission